CLASS II ONGOING Device recall · Reported 5 Jan 2022 · FDA Enforcement Report

Vidas Sars-cov-2 IgG recalled by bioMerieux

bioMerieux is recalling Vidas Sars-cov-2 IgG, distributed nationwide in the US. The recall was initiated on 22 Sep 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI 03573026620745, Lot #: 1008671430, 1008763910
Quantity recalledTwo lots

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0439-2022
FDA event ID
88797
Recalling firm
bioMerieux, Durham, NC
Classification
Class II
Status
Ongoing
Recall initiated
22 Sep 2021
FDA classified
28 Dec 2021
Reported
5 Jan 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

22 Sep 2021Recall initiated by company
28 Dec 2021Classified by FDA+97 days
5 Jan 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

Product as listed by the FDA

VIDAS SARS-COV-2 IgG, Ref 423834-01

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

Which lots are affected?

UDI 03573026620745, Lot #: 1008671430, 1008763910

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

15 other products · FDA event 88797

This product is part of a recall event; the main page for the event is Vidas RUB IgG (RBG) recalled by bioMerieux.

More recalls from bioMerieux

All 476

Other Other Medical Devices recalls

All 13,778